Search

everythinglearnresearchcommunity

for

Search:↓

A 50-year-old woman with breast cancer developed an autoimmune skin disorder, highlighting the need for thorough checks and team-based treatment.

Hormones affect skin aging, and treatments targeting hormonal balance may improve skin health.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Eph/ephrin signaling is important for skin cell behavior and could be targeted to treat skin diseases.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

A 7-year-old dog with a rare autoimmune disease was euthanized due to severe anemia and poor prognosis.

CD201+ fascia progenitors are essential for wound healing and could be targeted for treating skin conditions.

The symposium highlighted the importance of understanding disease mechanisms for targeted dermatology treatments.

Mixed Connective Tissue Disease can develop from overlapping symptoms of several autoimmune diseases, making diagnosis complex.

The mTOR signaling pathway is crucial for hair health and targeting it may lead to new hair loss treatments.

Changes in skin bacteria can affect hair loss and new treatments targeting these bacteria may prevent balding without sexual side effects.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Understanding embryologic layers improves skin disorder diagnosis and supports developing targeted therapies.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Different cell types work together to repair skin, and targeting them may improve healing and reduce scarring.

A sick foal with Rhodococcus equi pneumonia was successfully treated for multiple complications with targeted therapy and careful monitoring.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

Early recognition and a multidisciplinary approach are crucial for effectively managing complex autoimmune conditions like SLE with CAPS and AHA.

The S100A4 protein is more common in psoriatic skin and could be a target for treating psoriasis.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

The conclusion is that exogen is a unique hair cycle phase and the new sampling method specifically targets this stage, which may help in future hair loss research.

Inflammation and Demodex mites might contribute to hair loss, and targeting them could help treat it.

Females are more affected by immune-related skin diseases, needing targeted health interventions.

Alopecia areata involves specific gene changes and immune pathways, offering new treatment targets.